Abingdon Health PLC
LSE:ABDX

Watchlist Manager
Abingdon Health PLC Logo
Abingdon Health PLC
LSE:ABDX
Watchlist
Price: 8 GBX Market Closed
Market Cap: 15.5m GBX
Have any thoughts about
Abingdon Health PLC?
Write Note

Abingdon Health PLC
Investor Relations

Abingdon Health Plc develops, manufactures and commercializes immunoassay tests and reader systems. The company is headquartered in York, North Yorkshire and currently employs 151 full-time employees. The company went IPO on 2020-12-15. The firm operates through three segments: Contract Development, Contract Manufacturing and Product Sales. The Contract Development segment comprises development work for third parties and is recognized over time based on a proportion of completion. The Contract Manufacturing segment comprises contract development and manufacturing activities. The Product Sales segment comprises the sale of ABC-19, pocket diagnostic products, progressive rod cone degeneration (PCRD) tests and antibodies for research use. Its products also include Seralite, which includes Free Light Chain (FLC) Serum. The Company’s geographical market include the United Kingdom, the United States/Canada, rest of world (ROW).

Show more

Earnings Calls

No Earnings Calls Available

Management

Dr. Christopher William Hand
Executive Chairman
No Bio Available
Mr. Chris Henry Francis Yates
CEO, Company Secretary & Director
No Bio Available
Laura Towse
Group Financial Controller
No Bio Available
Mr. Mark Jones
Chief Operating Officer
No Bio Available

Contacts

Address
NORTH YORKSHIRE
York
York Biotech Campus, Sand Hutton
Contacts